- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03546790
Laboratory Smoking of Marijuana "Blunts"
September 30, 2019 updated by: Battelle Memorial Institute
This is a double-blind within-subjects clinical laboratory study comparing the product appeal and abuse liability-related subjective effects of different flavored cigar wrappers for marijuana blunts.
Study Overview
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21209
- Battelle Memorial Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Currently living in Baltimore City or Baltimore County, MD;
- Able to read, understand, and sign informed consent;
- 18-55 years old;
- Currently smokes marijuana blunts;
- Designation of Medically Healthy for Research by the Study Physician; and
- Willing to abstain from illicit drug use other than marijuana for the duration of the study.
Exclusion Criteria:
- BAC > 0.020% as measured by alcohol breathalyzer;
- Meets DSM-5 criteria for severe current or lifetime Cannabis Use Disorder;
- Meets DSM-5 criteria for any current Axis I disorder, other than current mild or moderate Cannabis Use Disorder;
- Self-reported current desire to stop marijuana use;
- Self-reported current asthma, chronic obstructive pulmonary disease, hypertension, cardiovascular disease or any other medical illness that precludes participation;
- Has difficulties with blood draws or poor venous access;
- History of blood donation in the past 30 days or receiving blood products within the past 2 months prior to any experimental visit;
- Among females, current pregnancy or lactation or attempting to get pregnant, or at risk of becoming pregnant;
- Acute illness which will require participant to be rescheduled
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Flavor 1
Grape flavored tobacco cigar wrapper
|
Marijuana smoked via blunts with different cigar wrappers
|
Experimental: Flavor 2
Chocolate flavored tobacco cigar wrapper
|
Marijuana smoked via blunts with different cigar wrappers
|
Experimental: Flavor 3
Tobacco flavored tobacco cigar wrapper
|
Marijuana smoked via blunts with different cigar wrappers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Puff topography
Time Frame: During marijuana blunt smoking
|
Total inhalation volume
|
During marijuana blunt smoking
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Carbon monoxide
Time Frame: Immediately after marijuana blunt smoking
|
Exhaled breath carbon monoxide (ppm)
|
Immediately after marijuana blunt smoking
|
Subjective drug effects
Time Frame: Immediately after marijuana blunt smoking
|
Ratings of "good" and "high"
|
Immediately after marijuana blunt smoking
|
Measures of demand
Time Frame: Immediately after marijuana blunt smoking
|
Number of units an individual would purchase at varying price points
|
Immediately after marijuana blunt smoking
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Wallace B Pickworth, PhD, Battelle Memorial Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 10, 2019
Primary Completion (Actual)
September 30, 2019
Study Completion (Actual)
September 30, 2019
Study Registration Dates
First Submitted
May 23, 2018
First Submitted That Met QC Criteria
June 4, 2018
First Posted (Actual)
June 6, 2018
Study Record Updates
Last Update Posted (Actual)
October 2, 2019
Last Update Submitted That Met QC Criteria
September 30, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BMI-104112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cannabis
-
Centre hospitalier de l'Université de Montréal...RecruitingCannabis | Cannabis Dependence | Cannabis Use | Cannabis Smoking | Cannabis Use, UnspecifiedCanada
-
Elias DakwarRecruitingAddiction | Cannabis Dependence | Cannabis Use | Substance Abuse | Cannabis Abuse | Cannabis Use DisorderUnited States
-
The University of Tennessee, KnoxvilleColorado State UniversityActive, not recruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
University College, LondonMedical Research Council; InvicroCompletedCannabis | Cannabis Dependence | Cannabis Use | CBD | Adolescent Development | THC | Marijuana | Cannabis IntoxicationUnited Kingdom
-
University of WashingtonNational Institute on Drug Abuse (NIDA)CompletedCannabis Dependence | Cannabis Abuse
-
Assistance Publique - Hôpitaux de ParisTerminatedCannabis Dependence | Cannabis AbuseFrance
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
University of VermontDartmouth College; Rutgers UniversityCompletedCannabis Use | Tolerance | Cannabis WithdrawalUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
Yale UniversityRobert E. Leet and Clara Guthrie Patterson Trust Mentored Research AwardRecruitingCannabis | Cannabis Use | Cannabis AbuseUnited States
Clinical Trials on Marijuana
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedMarijuana DependenceUnited States
-
Hartford HospitalYale UniversityRecruiting
-
University of California, San DiegoCompletedCannabis | Pain Syndrome | HIV NeuropathyUnited States
-
Center for Medicinal Cannabis ResearchCompletedHIV Infections | Peripheral Nervous System DiseasesUnited States
-
National Jewish HealthColorado Department of Public Health and EnvironmentUnknown
-
Massachusetts General HospitalCompletedDepression | Pain | Insomnia | AnxietyUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA); RTI International; National Institute...CompletedBehavioral Pharmacology of CannabisUnited States
-
University of California, San DiegoCompletedCannabis IntoxicationUnited States
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI); University of MinnesotaCompletedSickle Cell DiseaseUnited States
-
Unity Health TorontoUniversity Health Network, TorontoUnknown